I'm looking for a job. I exported this list from FewerJobs.com - a curated job board. Please: 1. Rank these jobs by fit for me, given my resume / skills. 2. Highlight the top 5 with a one-sentence rationale each. 3. Flag any concerns, including benefit values without source-backed evidence. 4. Suggest one or two filter changes I could make on FewerJobs to find more good matches. Filters I applied: - q: Corcept Therapeutics - quality_floor: default - match_401k_strict: true - parental_strict: true - non_birth_strict: true - pto_strict: true - include_older: false - apply_url_verified: false - page: 2 - per_page: 100 - sort: relevance Jobs (100 total): --- TITLE: Therapeutic Specialist I EMPLOYER: Gilead Sciences LOCATION: China - Kunming (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Kunming/Therapeutic-Specialist-I_R0052372-2 EXCERPT: Therapeutic Specialist I China - Kunming posted: Posted 30+ Days Ago --- TITLE: DMPK Scientist EMPLOYER: Arvinas Inc LOCATION: Remote, Hybrid, New Haven - CT (hybrid) SALARY: Not disclosed POSTED: 2026-05-06 APPLY_URL: https://job-boards.greenhouse.io/arvinas/jobs/7725520003 EXCERPT: DMPK Scientist Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the --- TITLE: Scientist, In Vivo Pharmacology EMPLOYER: Alnylam Pharmaceuticals LOCATION: United States | Cambridge, MA (unspecified) SALARY: Not disclosed POSTED: 2026-06-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://alnylam.eightfold.ai/careers/job/893394969861 EXCERPT: Scientist, In Vivo Pharmacology United States | Cambridge, MA --- TITLE: Therapeutic Specialist II EMPLOYER: Gilead Sciences LOCATION: China - Shenyang (unspecified) SALARY: Not disclosed POSTED: 2026-05-19 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Shenyang/Therapeutic-Specialist-I_R0051136-1 EXCERPT: Therapeutic Specialist II China - Shenyang posted: Posted 24 Days Ago --- TITLE: Patient Access Navigator EMPLOYER: Cogent Biosciences Inc LOCATION: Waltham, Massachusetts, United States (unspecified) SALARY: $170K-$200K POSTED: 2026-03-02 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4163457009 EXCERPT: Patient Access Navigator Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: Cogent Biosciences is searching for compassionate and highly motivated Patient Access Navigators to establish the inaugural Patient Services team. The Patient Access Navigators will be responsible for delivering a high-touch, patient-centered access experience across the prescription fulfillment journey. The Patient Access Navigator will own the end-to-end patient experience within an assigned geographic region and partners closely with patients, caregivers, healthcare providers (HCPs), specialty pharmacies, internal field teams, and external patient services partners to ensure timely access to therapy and continuity of care. While primarily remote/office-based (depending on location), the Patient Access Navigator will support limited non-promotional on-site visits to HCP offices, when appropriate, to support complex access, reimbursement or care coordination needs. The successful candidate will --- TITLE: Senior Therapeutic Specialist EMPLOYER: Gilead Sciences LOCATION: Norway - Oslo (unspecified) SALARY: Not disclosed POSTED: 2026-05-13 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Norway---Oslo/Senior-Therapeutic-Specialist_R0052304-1 EXCERPT: Senior Therapeutic Specialist Norway - Oslo posted: Posted 30 Days Ago --- TITLE: Senior Therapeutic Specialist II EMPLOYER: Gilead Sciences LOCATION: China - Tianjin (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Tianjin/Senior-Therapeutic-Specialist-II_R0052081-1 EXCERPT: Senior Therapeutic Specialist II China - Tianjin posted: Posted 30+ Days Ago --- TITLE: Principal Machine Learning Scientist, Drug Discovery Analytics EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $273K-$321K POSTED: 2026-04-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695388003 EXCERPT: Principal Machine Learning Scientist, Drug Discovery Analytics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Principal Machine Learning Scientist to lead the development of advanced machine learning approaches that accelerate small-molecule drug discovery. This role sits at the intersection of data science, chemistry, and biology, transforming complex scientific datasets into predictive models that guide target discovery, compound design, and translational hypotheses. Working closely with experimental scientists, the Principal ML Scientist will develop cutting-edge modeling approaches that integrate chemical, biological, and phenotypic data. The successful candidate will play a key role in advancing a data-driven discovery strategy by designing predictive models, deploying innovative algorithms, and translating insights into actionable decisions that improve the speed and success of the discovery of medicines for patients with RAS-driven cancers. Key responsibilities include: Scientific Leadership: - Define and lead machine learning strategies that accelerate early-stage drug discovery. - Identify opportunities where AI and advanced analytics can --- TITLE: Veterinary Integration Lead – Therapeutic Diagnostics EMPLOYER: Zoetis LOCATION: Parsippany (unspecified) SALARY: Not disclosed POSTED: 2026-05-21 K401_MATCH: yes (not source-backed) APPLY_URL: https://zoetis.wd5.myworkdayjobs.com/zoetis/job/Parsippany/Veterinary-Integration-Lead---Therapeutic-Diagnostics_JR00020827-1 EXCERPT: Veterinary Integration Lead – Therapeutic Diagnostics Parsippany posted: Posted 22 Days Ago --- TITLE: Sr Therapeutic Specialist - HIV EMPLOYER: Gilead Sciences LOCATION: Australia - Sydney (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Australia---Sydney/Sr-Therapeutic-Specialist_R0051369-2 EXCERPT: Sr Therapeutic Specialist - HIV Australia - Sydney posted: Posted 30+ Days Ago --- TITLE: Senior/Research Associate EMPLOYER: NewLimit LOCATION: South San Francisco (unspecified) SALARY: $75K-$100K POSTED: 2026-02-09 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/newlimit/jobs/5798299004 EXCERPT: Senior/Research Associate South San Francisco About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We're developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale. Position NewLimit is seeking an Senior/Research Associate with experience in discovery biology to join our Vascular therapeutic team. Our Vascular program is developing reprogramming medicines to restore youthful function in aged endothelial cells for the treatment of renal, cardiometabolic, and cognitive diseases. Your role will focus on supporting the development of in vitro assays and pre-clinical models to measure the functional decline that occurs in endothelial cells with age. You will collaborate closely with our scientists as well as our technology-focused teams to help create the first reprogramming medicines for the vascular tissue. What you'll do In your role as a Senior/Research Associate, you will: - Isolate cells from primary tissues to optimize in vitro functional assays - Develop pre‑clinical models of age-related dysfunction - Collaborate with our Single Cell Technology, Epigenetic Editing, and Predictive Modeling teams to design, build, and test epigenetic reprogramming interventions at scale - Support the development of in vivo nucleic acid delivery methods for endothelial cells - Analyze and interpret experimental data to drive pre-clinical decision making Requirements - Bachelor's degree in cell biology, molecular biology, biochemistry or --- TITLE: Sr Therapeutic Specialist (愛知県) - 肝臓領域 EMPLOYER: Gilead Sciences LOCATION: Japan - Tokyo (unspecified) SALARY: Not disclosed POSTED: 2026-06-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist------_R0052840-6 EXCERPT: Sr Therapeutic Specialist (愛知県) - 肝臓領域 Japan - Tokyo posted: Posted Today --- TITLE: Associate Director, Pharmacovigilance EMPLOYER: Dianthus Therapeutics LOCATION: Remote (remote) SALARY: Not disclosed POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/dianthustherapeutics/jobs/4691789005 EXCERPT: Associate Director, Pharmacovigilance Remote About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology - enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation - enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . About the Role As the Associate Director, Pharmacovigilance, you will work closely with the Safety team to support ongoing clinical trials. This role is critical in ensuring patient safety and regulatory compliance throughout the drug development lifecycle. Day to day, you will work closely with safety physicians, clinical teams, and external stakeholders to manage safety data and contribute to safety oversight. You must have experience reviewing adverse events, safety signals, and coordinate/contribute to the Safety Review Committee (SRC) and Drug Safety Monitoring Boards (DSMB) meetings. You must have experience supporting clinical pharmacovigilance activities and working with DSMBs in order to be successful in this role. This is a unique role that will allow you to work collaboratively with the growing pharmacovigilance team that is working closely with cross functional teams to help Dianthus elevate --- TITLE: Senior Manager/Associate Director, Marketing Operations EMPLOYER: Cogent Biosciences Inc LOCATION: Waltham, Massachusetts, United States (unspecified) SALARY: $175K-$200K POSTED: 2026-05-01 K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4238109009 EXCERPT: Senior Manager/Associate Director, Marketing Operations Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: This critical role will manage the tactical execution of marketing operations supporting the launch of bezuclastinib, Cogent Biosciences' key pipeline asset. This role ensures compliant, efficient, and impactful delivery of promotional content, omnichannel campaigns, key marketing KPI's. This role is critical to implementing. evolving and advancing our organization's omnichannel capabilities. The Senior Manager partners closely with brand leads to unify personal and non-personal promotional activities into a seamless customer experience that drives brand performance goals and commercial growth. Responsibilities: - Omnichannel Campaign Orchestration - Work with marketing to ensure the execution of complex customer engagement plans into high-performing omnichannel campaigns across HCP, patient, and caregiver audiences. - Collaborate with analytics teams to integrate insights --- TITLE: Sr Therapeutic Specialist（関西） EMPLOYER: Gilead Sciences LOCATION: Japan - Tokyo (unspecified) SALARY: Not disclosed POSTED: 2026-06-03 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist--_R0052782-4 EXCERPT: Sr Therapeutic Specialist（関西） Japan - Tokyo posted: Posted 9 Days Ago --- TITLE: Pharmacovigilance Scientist EMPLOYER: Stoke Therapeutics LOCATION: Bedford, Massachusetts, United States (unspecified) SALARY: $237K-$270K POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.stoketherapeutics.com/careers/job-opportunities/?gh_jid=4678619006 EXCERPT: Pharmacovigilance Scientist Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: We are building our Pharmacovigilance department in support of ongoing clinical development activities and NDA submission for a first-in-class antisense oligonucleotide (ASO) therapy in a rare pediatric neurological disease. The PV Scientist is a newly created role and a genuine opportunity to shape the scientific infrastructure of PV department at a critical inflection point. The PV Scientist is accountable for overall PV science support for pharmacovigilance department at Stoke, which includes working in collaboration with the Safety Physician(s) and cross-functional teams to lead signal detection activities conducted in the safety governance model within the company. The ideal candidate will have deep PV science experience and will contribute across clinical and regulatory workstreams --- TITLE: Head, Oncology Immune Therapeutics EMPLOYER: Novartis LOCATION: Cambridge (USA) (unspecified) SALARY: Not disclosed POSTED: 2026-05-21 K401_MATCH: yes (not source-backed) APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Cambridge-USA/Head--Oncology-Immune-Therapeutics_REQ-10078504 EXCERPT: Head, Oncology Immune Therapeutics Cambridge (USA) posted: Posted 22 Days Ago --- TITLE: Associate Scientist, Obesity, Muscle and Metabolism EMPLOYER: Regeneron Pharmaceuticals LOCATION: TARRYTOWN (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://regeneron.wd1.myworkdayjobs.com/Careers/job/TARRYTOWN/Associate-Scientist--Obesity--Muscle-and-Metabolism_R47998 EXCERPT: Associate Scientist, Obesity, Muscle and Metabolism TARRYTOWN posted: Posted 2 Days Ago --- TITLE: Information Security Lead EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $130K-$200K POSTED: 2026-02-25 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8414783002 EXCERPT: Information Security Lead New York, NY Who We Are: Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As Information Security Lead, you'll be at the forefront of safeguarding our groundbreaking digital therapeutics. We're seeking an individual with deep technical expertise in information security in the healthcare sector, ready to tackle complex challenges and pioneer innovative solutions. This isn't just a role; it's an opportunity to build, mentor, and inspire a high-performing team, while strategically collaborating across --- TITLE: Senior Scientist, Multiomic Therapeutics EMPLOYER: Johnson & Johnson LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://jj.wd5.myworkdayjobs.com/JJ/job/Madrid-Spain/Senior-Scientist--Multiomic-Therapeutics_R-059563 EXCERPT: Senior Scientist, Multiomic Therapeutics 2 Locations posted: Posted 8 Days Ago --- TITLE: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy HARTFORD, CT EMPLOYER: Bristol Myers Squibb LOCATION: Hartford - CT - US (unspecified) SALARY: Not disclosed POSTED: 2026-05-22 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Hartford---CT---US/Senior-Therapeutic-Area-Specialist--Neuroscience---Cobenfy-HARTFORD--CT_R1602728 EXCERPT: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy HARTFORD, CT Hartford - CT - US posted: Posted 21 Days Ago --- TITLE: CV Therapeutic Area Lead EMPLOYER: Amgen LOCATION: South Korea - Seoul (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 PARENTAL_LEAVE_WEEKS: 6 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://amgen.wd1.myworkdayjobs.com/Careers/job/South-Korea---Seoul/CV-Therapeutic-Area-Lead_R-234326-3 EXCERPT: CV Therapeutic Area Lead South Korea - Seoul posted: Posted 30+ Days Ago --- TITLE: Senior Research Scientist - Neuroscience EMPLOYER: Arvinas Inc LOCATION: New Haven - CT (unspecified) SALARY: Not disclosed POSTED: 2026-05-25 APPLY_URL: https://job-boards.greenhouse.io/arvinas/jobs/7747837003 EXCERPT: Senior Research Scientist - Neuroscience New Haven - CT Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development. #TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. --- TITLE: Senior Therapeutic Specialist, Oncology EMPLOYER: Gilead Sciences LOCATION: 7 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Senior-Therapeutic-Specialist--Oncology_R0052354-1 EXCERPT: Senior Therapeutic Specialist, Oncology 7 Locations posted: Posted 30+ Days Ago --- TITLE: Scientist, Medicinal Chemistry EMPLOYER: General Proximity LOCATION: San Francisco, CA (unspecified) SALARY: Not disclosed POSTED: 2026-05-29 APPLY_URL: https://job-boards.greenhouse.io/generalproximity/jobs/6009487004 EXCERPT: Scientist, Medicinal Chemistry San Francisco, CA tl;dr General Proximity is a seed-stage startup developing the next generation of induced proximity medicines (IPMs). Our OmniTAC drug discovery engine furnishes molecules that co-opt existing cellular machinery to overcome therapeutic challenges, which have remained unapproachable to other modalities for decades. We are seeking a first-rate medicinal chemist to help us pioneer this uncharted frontier of drug discovery. Our Story A long-standing challenge in drug discovery is the development of molecules capable of modulating difficult or "undruggable" targets. Disease-causing proteins can be dysfunctional in many different ways, but our armamentarium for fixing them is quite limited. The most common mechanism of action for FDA-approved drugs is inhibition [1] , but there are many other possible perturbation types whose potential remains unrealized. General Proximity is a seed-stage drug discovery company developing a novel platform technology to solve this problem. We make bifunctional drugs that induce the modification of drug targets by existing cellular machinery (rather than through direct modulation by the drug, the classical approach). Historically, the development of technologies that allow one to push new buttons in biology has been an incredibly fertile field for the discovery of new medicines[ 2 , 3 , 4 ], and our technology holds the same promise. The Position We are seeking a medicinal chemist to be a member of our Chemistry/Drug Discovery Team. In this position, you will work with both our Chemistry and Platform Teams in the development of our core drug discovery technology and the --- TITLE: Associate Scientist II, In Vivo Pharmacology EMPLOYER: AbbVie Inc. LOCATION: North Chicago, IL, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013377396-associate-scientist-ii-in-vivo-pharmacology EXCERPT: Associate Scientist II, In Vivo Pharmacology North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: The In Vivo Pharmacology / Oncology Discovery Research group seeks to hire a highly motivated tumor biologist (G13) to support discovery and development of innovative oncology therapeutics, both small molecule and biologics. The successful candidate will have proven expertise with the design and execution of studies to determine efficacy, PK/PD relationships, and MTD of oncology drugs in both immunocompetent and immunocompromised mouse models. The candidate should be experienced with drug formulation and administration via SC, PO, IP, IM and IV routes. Additional ability to develop, maintain, and preserve patient-derived xenograft models, and to utilize optical imaging approaches in vivo with appropriate instrumentation, are both a plus. Familiarity with data analysis, presentation design and communication, management, and statistical software (e.g. Microsoft Office Suite, Study Director) is necessary. Our scientists interact with in vitro biology, translational/biomarkers, medicinal chemistry, and husbandry teams to advance oncology agents through the R&D pipeline, therefore excellent communication skills and the willingness to work with --- TITLE: Principal Scientist, Peptide Therapeutics EMPLOYER: Genentech, Inc. LOCATION: South San Francisco, California, United States of America (unspecified) SALARY: Not disclosed POSTED: 2026-02-24 K401_MATCH: yes (not source-backed) APPLY_URL: https://roche.wd3.myworkdayjobs.com/ROG-A2O-GENE/job/South-San-Francisco/Principal-Scientist--Peptide-Therapeutics_202602-103654/apply EXCERPT: Principal Scientist, Peptide Therapeutics South San Francisco, California, United States of America This is a primarily lab-based, technical leadership position within the Peptide Therapeutics department. In this lab-based leadership role, you will combine hands-on synthetic expertise with strategic... --- TITLE: Sr. Therapeutic Specialist- RA（愛知） EMPLOYER: Gilead Sciences LOCATION: Japan - Tokyo (unspecified) SALARY: Not disclosed POSTED: 2026-05-25 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist--RA--_R0049919-1 EXCERPT: Sr. Therapeutic Specialist- RA（愛知） Japan - Tokyo posted: Posted 18 Days Ago --- TITLE: Associate Director, Biostatistics EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $184K-$209K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5848284004 EXCERPT: Associate Director, Biostatistics Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! As an Associate Director, Biostatistics this person will provide statistical support for pipeline compounds' clinical development, regulatory filing, and commercialization. Reporting to Vice President, Head of Biometrics and Data Science, the successful candidate will serve as the biostatistician for assigned clinical trials to provide statistical leadership from trial design, data analysis, to results interpretation and dissemination. This role will also provide statistical support to regulatory filing --- TITLE: Therapeutic Specialist - Miami North EMPLOYER: Insmed Incorporated LOCATION: Miami N, FL (unspecified) SALARY: Not disclosed POSTED: 2026-05-20 APPLY_URL: https://insmed.wd5.myworkdayjobs.com/External/job/Miami-N-FL/Therapeutic-Specialist---Miami-North_R3479 EXCERPT: Therapeutic Specialist - Miami North Miami N, FL posted: Posted 23 Days Ago --- TITLE: Senior Scientist II / Principal Scientist I, Biologics Drug Product Development EMPLOYER: AbbVie Inc. LOCATION: North Chicago, IL, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013490176-senior-scientist-ii-principal-scientist-i-biologics-drug-product-development EXCERPT: Senior Scientist II / Principal Scientist I, Biologics Drug Product Development North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: Description: Biologics Drug Product Development (Bio DPD), a part of Development Sciences within AbbVie's R&D, is a global organization that is responsible for drug product formulation and process development, and definition of the product presentation for biologics (proteins, conjugates, peptides, neurotoxins etc.) and genetic medicine (AAV, LNPs, Cell Therapy). AbbVie is seeking a highly motivated candidate for the position of Senior Scientist II / Principal Scientist I, located in North Chicago, IL. We are seeking an accomplished scientist with a proven track record in biologics drug product formulation and process development, scale-up and tech transfer. This position will be an integral part of the product development and CMC teams and will have strong collaborations with several stakeholders, including discovery research, analytical research and development, bioprocess development, combination products development, product development science and technology, pilot plants and third-party manufacturers. Key Responsibilities: Represent Bio DPD in the cross-functional Product Presentation and Device Strategy --- TITLE: Associate Director Therapeutic Area Genetics (Immunology) EMPLOYER: Regeneron Pharmaceuticals LOCATION: TARRYTOWN (unspecified) SALARY: Not disclosed POSTED: 2026-06-08 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://regeneron.wd1.myworkdayjobs.com/Careers/job/TARRYTOWN/Associate-Director-Therapeutic-Area-Genetics--Immunology-_R46254 EXCERPT: Associate Director Therapeutic Area Genetics (Immunology) TARRYTOWN posted: Posted 4 Days Ago --- TITLE: Associate Scientist II, Drug Metabolism and Distribution EMPLOYER: AbbVie Inc. LOCATION: North Chicago, IL, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013523566-associate-scientist-ii-drug-metabolism-and-distribution EXCERPT: Associate Scientist II, Drug Metabolism and Distribution North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: We are seeking an Associate Scientist II to join our Drug Metabolism and Disposition Team within the Quantitative Translation and ADME Sciences organization in Development Sciences at AbbVie Pharmaceuticals. This position is an opportunity to join a dynamic team and work on in vitro and in vivo biotransformation studies. In this role, you will leverage cutting-edge analytical technologies and workflows to solve problems, advance our pipeline and drive pharmaceutical innovation. The ideal candidate will combine strong technical expertise with a desire to learn and grow and create solutions that will accelerate drug discovery and improve patient outcomes. This role will work collaboratively with multiple teams within Discovery, Development Sciences and the Clinical Pharmacology organization to perform analyses and implement technologies to deliver precise, reliable, and reproducible solutions. Communication skills are key to being able to interface with technical and non-technical stakeholders. Responsibilities Perform routine tasks competently and independently and generate reliable and consistent results. Lab based --- TITLE: Therapeutic Area Head, Oncology EMPLOYER: Bristol Myers Squibb LOCATION: Uxbridge - GB (unspecified) SALARY: Not disclosed POSTED: 2026-05-26 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Uxbridge---GB/Therapeutic-Area-Head--Oncology_R1602621 EXCERPT: Therapeutic Area Head, Oncology Uxbridge - GB posted: Posted 17 Days Ago --- TITLE: Therapeutic Specialist, Hepatology - BC & Saskatchewan EMPLOYER: GSK plc LOCATION: 5 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-19 K401_MATCH: yes (not source-backed) APPLY_URL: https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada--British-Columbia--Vancouver/Therapeutic-Specialist--Hepatology---BC---Saskatchewan_439650-1 EXCERPT: Therapeutic Specialist, Hepatology - BC & Saskatchewan 5 Locations posted: Posted 24 Days Ago --- TITLE: Principal Scientist, Cancer Pharmacology, Translational Research EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $190K-$238K POSTED: 2026-05-21 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7746574003 EXCERPT: Principal Scientist, Cancer Pharmacology, Translational Research Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Principal Scientist in the Cancer Pharmacology team within the Translational Research group, in the Biomedical Discovery Research Department, you will: - Provide scientific and strategic leadership for RAS(ON) inhibitor programs by translating mechanistic insights in RAS biology into impactful pharmacology strategies and translational study plans. - Lead, mentor, and develop a high-performing group of in vivo scientists, fostering scientific excellence, innovation, and cross-functional collaboration. - Drive the design, execution, and interpretation of in vivo efficacy and PK/PD studies conducted internally and through external partners to advance oncology discovery and development programs. - Partner closely with the cross-functional quantitative modeling group to provide biological insight, translational context, and critical evaluation supporting PK/PD modeling efforts. - Influence portfolio progression through generation of high-impact data packages and contributions to regulatory submissions. - Serve as the in vivo pharmacology expert on cross-functional project --- TITLE: Therapeutic Specialist, Salt Lake City EMPLOYER: Insmed Incorporated LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-08 APPLY_URL: https://insmed.wd5.myworkdayjobs.com/External/job/NJ-Corporate-Headquarters/Therapeutic-Specialist--Salt-Lake-City_R3512 EXCERPT: Therapeutic Specialist, Salt Lake City 2 Locations posted: Posted 4 Days Ago --- TITLE: Director, Therapeutic Area Strategy, CRM EMPLOYER: Novartis LOCATION: Basel (City) (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Basel-City/Director--CRM-Therapeutic-Area-Strategy_REQ-10076215-1 EXCERPT: Director, Therapeutic Area Strategy, CRM Basel (City) posted: Posted 30+ Days Ago --- TITLE: Head of DMPK EMPLOYER: General Proximity LOCATION: San Francisco, CA (unspecified) SALARY: Not disclosed POSTED: 2026-05-15 APPLY_URL: https://job-boards.greenhouse.io/generalproximity/jobs/5997363004 EXCERPT: Head of DMPK San Francisco, CA tl;dr General Proximity is a seed-stage startup developing the next generation of induced proximity medicines (IPMs). Our OmniTAC drug discovery engine furnishes molecules that co-opt existing cellular machinery to overcome therapeutic challenges, which have remained unapproachable to other modalities for decades. We are seeking a first-rate DMPK expert to help us pioneer this uncharted frontier of drug discovery. Our Story A long-standing challenge in drug discovery is the development of molecules capable of modulating difficult or "undruggable" targets. Disease-causing proteins can be dysfunctional in many different ways, but our armamentarium for fixing them is quite limited. The most common mechanism of action for FDA-approved drugs is inhibition [1] , but there are many other possible perturbation types whose potential remains unrealized. General Proximity is a seed-stage drug discovery company developing a novel platform technology to solve this problem. We make bifunctional drugs that induce the modification of drug targets by existing cellular machinery (rather than through direct modulation by the drug, the classical approach). Historically, the development of technologies that allow one to push new buttons in biology has been an incredibly fertile field for the discovery of new medicines[ 2 , 3 , 4 ], and our technology holds the same promise. The Position We are seeking an experienced Head of DMPK to lead and shape our drug metabolism and pharmacokinetics function. This is a high-impact leadership role in which you will own the DMPK strategy across our small molecule portfolio, build and --- TITLE: Associate Director, in Vivo Pharmacology EMPLOYER: Crinetics Pharmaceuticals INC LOCATION: San Diego, CA (unspecified) SALARY: $160K-$200K POSTED: 2026-05-15 K401_MATCH: yes (not source-backed) APPLY_URL: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/San-Diego-CA/Associate-Director--in-Vivo-Pharmacology_JR000625 EXCERPT: Associate Director, in Vivo Pharmacology San Diego, CA Crinetics is a pharmaceutical company based in San Diego, California, developing much-needed therapies for people with endocrine diseases and endocrine-related tumors. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and a robust preclinical and clinical development pipeline. We are driven by science with a patient-centric and team-oriented culture. Crinetics is known for its inclusive workplace culture. We are also a dog-friendly workplace. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully integrated endocrine company from discovery to patients. Join our team as we transform the lives of others. Position Summary: The Associate Director, In Vivo Pharmacology, will be responsible for providing in vivo pharmacology support to Endocrine Discovery teams including designing, conducting, and interpreting experiments to demonstrate efficacy and evaluate safety of novel nonpeptides in animal models. The candidate will have a broad background in in vivo pharmacology and will contribute to several preclinical programs as well as the identification of new therapeutic targets. Essential Job Functions and Responsibilities: These may include but are not limited to: Lead the Endocrine Discovery In Vivo Pharmacology team to plan, design, conduct, and interpret in vivo experiments to evaluate the efficacy, pharmacokinetics, and safety of therapeutic candidate molecules in support --- TITLE: Therapeutic Specialist, HCV/PBC -- Macon/Savannah EMPLOYER: Gilead Sciences LOCATION: United States - Field (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Sr-Therapeutic-Specialist--HCV-PBC----Macon-Savannah_R0050403 EXCERPT: Therapeutic Specialist, HCV/PBC -- Macon/Savannah United States - Field posted: Posted 30+ Days Ago --- TITLE: Senior Director, Marketing EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $252K-$295K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5985751004 EXCERPT: Senior Director, Marketing Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key --- TITLE: Therapeutic Specialist - Northern Houston EMPLOYER: Insmed Incorporated LOCATION: North Houston, TX (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 APPLY_URL: https://insmed.wd5.myworkdayjobs.com/External/job/North-Houston-TX/Therapeutic-Specialist---Northern-Houston_R3236 EXCERPT: Therapeutic Specialist - Northern Houston North Houston, TX posted: Posted 30+ Days Ago --- TITLE: Senior Scientist I, Computational Chemistry EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $149K-$186K POSTED: 2026-04-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695451003 EXCERPT: Senior Scientist I, Computational Chemistry Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated Senior Scientist I to join our dynamic Computational Chemistry team.This position offers an exciting opportunity to drive drug discovery through cutting-edge computational methods, working at the intersection of structural biology, medicinal chemistry, biology, and data science to accelerate the development of transformative therapeutics for patients. As a key contributor in our Computational Chemistry team, you will: - Partner with multidisciplinary, collaborative teams in Discovery Sciences to design, optimize, and accelerate the discovery of novel drug candidates using structure-based computational methods. - Analyze structure-activity relationships (SAR) and make data-driven decisions by systematically following existing SAR trends to guide compound prioritization and design strategies for Ro5 and bRo5 molecules. - Partner closely with Medicinal Chemists to prioritize compound designs both independently and collaboratively, effectively communicating scientific rationale and recommendations to diverse interdisciplinary teams. - Design and implement virtual screening --- TITLE: Director, Therapeutic Area Strategy, Immunology EMPLOYER: Novartis LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Cambridge-USA/Director--Therapeutic-Area-Strategy--Immunology_REQ-10076236 EXCERPT: Director, Therapeutic Area Strategy, Immunology 2 Locations posted: Posted 30+ Days Ago --- TITLE: Director, CVRM Genomics Therapeutic Area Lead EMPLOYER: AstraZeneca LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-08 K401_MATCH: yes (not source-backed) APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/US---Boston---MA/Senior-Director--CVRM-Genomics-Therapeutic-Area-Lead_R-254044 EXCERPT: Director, CVRM Genomics Therapeutic Area Lead 2 Locations posted: Posted 4 Days Ago --- TITLE: Associate Scientist – In Vivo Pharmacology, Cardiometabolic Disorders EMPLOYER: Amgen LOCATION: US - California - South San Francisco (unspecified) SALARY: Not disclosed POSTED: 2026-05-13 PARENTAL_LEAVE_WEEKS: 6 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://amgen.wd1.myworkdayjobs.com/Careers/job/US---California---South-San-Francisco/Associate-Scientist---In-Vivo-Pharmacology_R-241253 EXCERPT: Associate Scientist – In Vivo Pharmacology, Cardiometabolic Disorders US - California - South San Francisco posted: Posted 30 Days Ago --- TITLE: Senior Director, Commercial Manufacturing, Science and Technology EMPLOYER: Cogent Biosciences Inc LOCATION: Remote, United States (remote) SALARY: $240K-$280K POSTED: 2026-05-20 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4254112009 EXCERPT: Senior Director, Commercial Manufacturing, Science and Technology Remote, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: This position oversees late phase through commercialization small molecule drug product manufacturing at partner Contract Development and Manufacturing Organizations (CDMOs) and ensures high-quality products are delivered on time and within budget. Serve as a technical expert who leads the transfer of manufacturing processes to commercial scale. Manage processes, systems and infrastructure that meet safety, cGMP manufacturing, and regulatory compliance. Provide technical expertise and oversight for process validation, lifecycle management, and continuous improvement. Anticipate and solve complex manufacturing issues. Work in collaboration with internal and external stakeholders including CMC, Quality, Supply Chain and Regulatory, as well as CDMOs. Responsibilities: - Lead commercial drug product CMC lifecycle activities such as post-approval change management, process validation --- TITLE: Sr / Therapeutic Specialist - Oncology EMPLOYER: Gilead Sciences LOCATION: China - Hong Kong (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Hong-Kong/Sr---Therapeutic-Specialist---Oncology_R0051908-1 EXCERPT: Sr / Therapeutic Specialist - Oncology China - Hong Kong posted: Posted 30+ Days Ago --- TITLE: Therapeutic Area Head, Psychiatry & Neuroscience Portfolio EMPLOYER: Bristol Myers Squibb LOCATION: Uxbridge - GB (unspecified) SALARY: Not disclosed POSTED: 2026-06-11 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Uxbridge---GB/Therapeutic-Area-Head--Psychiatry---Neuroscience-Portfolio_R1603331 EXCERPT: Therapeutic Area Head, Psychiatry & Neuroscience Portfolio Uxbridge - GB posted: Posted Yesterday --- TITLE: Scientist II/Senior Scientist, Medicinal Chemistry EMPLOYER: General Proximity LOCATION: San Francisco, CA (unspecified) SALARY: Not disclosed POSTED: 2026-04-23 APPLY_URL: https://job-boards.greenhouse.io/generalproximity/jobs/5980552004 EXCERPT: Scientist II/Senior Scientist, Medicinal Chemistry San Francisco, CA tl;dr General Proximity is a seed-stage startup developing the next generation of induced proximity medicines (IPMs). Our OmniTAC drug discovery engine furnishes molecules that co-opt existing cellular machinery to overcome therapeutic challenges, which have remained unapproachable to other modalities for decades. We are seeking a first-rate medicinal chemist to help us pioneer this uncharted frontier of drug discovery. Our Story A long-standing challenge in drug discovery is the development of molecules capable of modulating difficult or "undruggable" targets. Disease-causing proteins can be dysfunctional in many different ways, but our armamentarium for fixing them is quite limited. The most common mechanism of action for FDA-approved drugs is inhibition [1] , but there are many other possible perturbation types whose potential remains unrealized. General Proximity is a seed-stage drug discovery company developing a novel platform technology to solve this problem. We make bifunctional drugs that induce the modification of drug targets by existing cellular machinery (rather than through direct modulation by the drug, the classical approach). Historically, the development of technologies that allow one to push new buttons in biology has been an incredibly fertile field for the discovery of new medicines[ 2 , 3 , 4 ], and our technology holds the same promise. The Position We are seeking an exceptional medicinal chemist to join our Chemistry and Drug Discovery team. This is a rare opportunity to help build a next-generation drug discovery company from the ground up and contribute directly to the --- TITLE: Team Lead, Therapeutic Area Quality EMPLOYER: GSK plc LOCATION: 5 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-05 K401_MATCH: yes (not source-backed) APPLY_URL: https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---Massachusetts---Boston/Team-Lead--Therapeutic-Area-Quality_442214 EXCERPT: Team Lead, Therapeutic Area Quality 5 Locations posted: Posted 7 Days Ago --- TITLE: Associate Director/Director, Technical Operations - Drug Substance (Small Molecules) EMPLOYER: Axsome Therapeutics LOCATION: New York, NY (unspecified) SALARY: $175K-$215K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/axsometherapeutics/jobs/5980968004 EXCERPT: Associate Director/Director, Technical Operations - Drug Substance (Small Molecules) New York, NY Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain's biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X . About This Role: Axsome Therapeutics is seeking an Associate Director/Director, Technical Operations - Drug Substance (Small Molecules) to provide technical leadership across the development and commercial lifecycle of small‑molecule drug substance programs. This role is responsible for supporting and overseeing drug substance manufacturing activities, including technology transfer, process validation, continued process verification (CPV), and post‑approval process changes at internal and external manufacturing sites. The successful candidate will serve as a key technical leader within CMC, partnering closely with external CDMOs and internal cross‑functional teams (QA, QC, Regulatory, R&D, and Supply Chain) to ensure robust, compliant, and efficient manufacturing operations. This position reports into senior --- TITLE: Cell Therapy Data and AI Productivity EMPLOYER: AstraZeneca LOCATION: US - South San Francisco - CA (unspecified) SALARY: Not disclosed POSTED: 2026-05-22 K401_MATCH: yes (not source-backed) APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/US---South-San-Francisco---CA/Cell-Therapy-Data-and-AI-Productivity_R-252976 EXCERPT: Cell Therapy Data and AI Productivity US - South San Francisco - CA posted: Posted 21 Days Ago --- TITLE: Senior Director/Vice President, Market Access EMPLOYER: Click Therapeutics LOCATION: New York, NY (unspecified) SALARY: $180K-$280K POSTED: 2026-04-21 K401_MATCH: yes (not source-backed) FERTILITY_FAMILY_BUILDING_BENEFITS: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8515744002 EXCERPT: Senior Director/Vice President, Market Access New York, NY Who We Are : Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As a Senior Director / Vice President of Market Access, you will be the backbone of the commercial organization. You will design the financial architecture of the product, shape the external policy and regulatory environments to support PDTs, and ensure long term viability of the PDT category. The role reports to the Chief Commercial Officer and --- TITLE: Therapeutic Area Head – Respiratory EMPLOYER: Apogee Therapeutics Inc LOCATION: Remote (remote) SALARY: $395K-$425K POSTED: 2026-06-11 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/apogeetherapeutics/jobs/5160938007 EXCERPT: Therapeutic Area Head – Respiratory Remote About Apogee Therapeutics Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care. We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at “good enough”. If this sounds like you, keep reading! Role Summary We are seeking a Therapeutic Area (TA) Head, Respiratory - Clinical Development. In this --- TITLE: Sr. Medical Director, Pharmacovigilance EMPLOYER: Stoke Therapeutics LOCATION: Bedford, Massachusetts, United States (unspecified) SALARY: $327K-$360K POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.stoketherapeutics.com/careers/job-opportunities/?gh_jid=4671447006 EXCERPT: Sr. Medical Director, Pharmacovigilance Bedford, Massachusetts, United States About Stoke: Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Using Stoke's proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke's first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke's initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke's proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/ Position Purpose: The Senior Medical Director, Pharmacovigilance will be responsible for the medical review of adverse event data, the development of company causality assessment frameworks in post-marketing surveillance, and leading signal detection and management activities. This individual will work in close partnership with PV operations to build rigorous, scalable, medical safety practices suited to a clinical development and complex postmarketing environment. This position will report into the Head of Pharmacovigilance. This is a role for a physician who is energized by developing business practice frameworks and review processes that a growing medical safety function requires and leading the medical safety domain within the organization. Rare disease carries meaningful responsibility to patient and --- TITLE: Director, Imaging Biomarkers EMPLOYER: DYNE Therapeutics LOCATION: Waltham, MA (unspecified) SALARY: $196K-$240K POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/dynetherapeutics/jobs/5781107004 EXCERPT: Director, Imaging Biomarkers Waltham, MA Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook . Role Summary: The Director of Imaging Biomarkers lead s the development and execution of innovative imaging strategies across Dyne's therapeutic programs. This pivotal role will ensur e that imaging biomarker strategies are scientifically rigorous, clinically relevant, and condu cive to robust therapeutic development. The person in this role focuses on enhancing the understanding of disease mechanisms , patient populations, evaluating therapeutic efficacy, and supporting clinical trial designs through innovative imaging approaches. This role is cri tical to linking early phase research to clinical development, providing essential insights that drive decision making. The person in this role leverages their expertise in various imaging modalities to develop novel biomarker applications that assess therapeutic efficacy, drive patient-centric trial designs, and facilitate regulatory approval processes. This role combines scientific depth with strategic vision, driving the discovery, validation, and application of advanced imaging modalities to enable precision medicine and accelerate --- TITLE: Senior Scientist, Obesity, Muscle & Metabolism EMPLOYER: Regeneron Pharmaceuticals LOCATION: TARRYTOWN (unspecified) SALARY: Not disclosed POSTED: 2026-06-08 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://regeneron.wd1.myworkdayjobs.com/Careers/job/TARRYTOWN/Senior-Scientist--Obesity--Muscle---Metabolism_R47888-1 EXCERPT: Senior Scientist, Obesity, Muscle & Metabolism TARRYTOWN posted: Posted 4 Days Ago --- TITLE: Therapeutic Area Strategy Director, Oncology & Hematology EMPLOYER: Novartis LOCATION: Basel (City) (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Basel-City/Therapeutic-Area-Strategy-Executive-Director--Oncology---Hematology_REQ-10074747 EXCERPT: Therapeutic Area Strategy Director, Oncology & Hematology Basel (City) posted: Posted 30+ Days Ago --- TITLE: Associate Director, Clinical Development EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $170K-$192K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5977186004 EXCERPT: Associate Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Associate Director, Clinical Development plays a key role in the design and execution of ongoing and new clinical development studies. This position serves as the clinical science representative on one or more U.S. and/or global clinical studies and contributes to the delivery of high‑quality clinical data to support registration and launch. The role partners cross‑functionally with Clinical Operations, Clinical Pharmacology, Regulatory Affairs, Early Development, --- TITLE: Therapeutic Specialist - Hepatitis B/D - Minneapolis, MN EMPLOYER: Gilead Sciences LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Therapeutic-Specialist---Hepatitis-B-D---Minneapolis--MN_R0050306 EXCERPT: Therapeutic Specialist - Hepatitis B/D - Minneapolis, MN 2 Locations posted: Posted 30+ Days Ago --- TITLE: Senior Director, Clinical Development EMPLOYER: Dianthus Therapeutics LOCATION: Remote (remote) SALARY: Not disclosed POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/dianthustherapeutics/jobs/4683188005 EXCERPT: Senior Director, Clinical Development Remote About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology - enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation - enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . About the Role The Senior Medical Director, Clinical Development will be the clinical and medical strategic lead of one or more clinical trials for DNTH212. Reporting to the SVP, Clinical Development, you will steer the preparation, review and execution of clinical study synopses and protocols, investigator brochures, and clinical study reports; review SAPs and TLF shells, guide the evaluation of emerging clinical trial data, oversee/guide the data interpretation and data mining, and ensure assigned studies are conducted according to GCPs and SOPs. You will act as a the medical monitor in close collaboration with the CRO medical and clinical monitors, ensure timely recruitment in collaboration with clinical operations, oversee/guide in conducting literature searches and reviews, meta-analyses, and publishing data. You must have experience with Rare Diseases or Rheumatology within the biotechnology or pharmaceutical --- TITLE: Senior Director, Therapeutic Area EMPLOYER: Piedmont Healthcare LOCATION: US, Blue Bell (ICON) (unspecified) SALARY: Not disclosed POSTED: 2026-05-14 K401_MATCH: yes (not source-backed) APPLY_URL: https://icon.wd3.myworkdayjobs.com/broadbean_external/job/US-Blue-Bell-ICON/Senior-Director--Therapeutic-Area_JR146925-1 EXCERPT: Senior Director, Therapeutic Area US, Blue Bell (ICON) posted: Posted 29 Days Ago --- TITLE: Early Development Team Leader EMPLOYER: Arvinas Inc LOCATION: Remote, Hybrid, New Haven - CT (hybrid) SALARY: Not disclosed POSTED: 2026-04-01 HIRE_STATES: CT APPLY_URL: https://job-boards.greenhouse.io/arvinas/jobs/7686687003 EXCERPT: Early Development Team Leader Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: ARV-102 for the treatment of patients with neurodegenerative disorders,ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas, and ARV-806, a KRAS G12D PROTAC for the treatment patients with solid tumors with KRAS G12D mutations. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical --- TITLE: Senior Manager, Trade and Distribution EMPLOYER: Cogent Biosciences Inc LOCATION: Waltham, Massachusetts, United States (unspecified) SALARY: $175K-$205K POSTED: 2026-03-25 K401_MATCH: yes (not source-backed) LEARNING_BUDGET_OFFERED: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4195598009 EXCERPT: Senior Manager, Trade and Distribution Waltham, Massachusetts, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Senior Manager of Trade and Distribution will be responsible for management of Cogent Bioscience's network of Specialty Distributor accounts. The Key responsibilities will be to oversee the physical and financial flow of the Cogent Biosciences portfolio beginning with the launch of Bezuclastinib. The candidate will be the primary for Specialty Distributor customers tasked with maintaining relationships and growing Cogent Biosciences business while contributing to the evolving channel strategy for products. This candidate will oversee all aspects of business operations within assigned customers including inventory management, product fulfillment, data flow and management of returns. The individual will report to the Executive Director Trade & Distribution within the Market Access team and work closely with --- TITLE: Therapeutics Lead - Specialty EMPLOYER: GSK plc LOCATION: Vietnam - Ho Chi Minh City (unspecified) SALARY: Not disclosed POSTED: 2026-05-15 K401_MATCH: yes (not source-backed) APPLY_URL: https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Vietnam---Ho-Chi-Minh-City/Therapeutics-Lead---Specialty_439022 EXCERPT: Therapeutics Lead - Specialty Vietnam - Ho Chi Minh City posted: Posted 28 Days Ago --- TITLE: Senior Director & Therapeutic Area Head, Regulatory Affairs EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $244K-$305K POSTED: 2026-04-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695273003 EXCERPT: Senior Director & Therapeutic Area Head, Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: - Provide management and leadership of one or more therapeutic areas for late-stage oncology programs. - Oversee the development of global regulatory therapeutic area and product strategies to drive product development, global registration, , and effective regulatory agency interactions. - Provide regulatory expertise and guidance to therapeutic area commercialization teams and other governance bodies. - Foster the career development of staff within the therapeutic area and contribute to departmental leadership activities. - Ensure alignment and consistency across programs within a therapeutic area based on regulatory intel, research, and competitive landscape. Primary Responsibilities: - Direct the development of global regulatory strategy from registrational studies to marketing application across one or more therapeutic areas. - Lead and mentor GRLs/Study Leads in the development of global regulatory strategies, in partnership with regional regulatory leads, including precedence, risk management and contingency planning. - --- TITLE: Senior Scientist II - Biologics Drug Product Development EMPLOYER: AbbVie Inc. LOCATION: North Chicago, IL, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-12 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013581601-senior-scientist-ii-biologics-drug-product-development EXCERPT: Senior Scientist II - Biologics Drug Product Development North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: Biologics Drug Product Development (Bio DPD), a part of Development Sciences within AbbVie's R&D, is a global organization that is responsible for drug product formulation and process development, and definition of the product presentation for biologics (proteins, conjugates, peptides, neurotoxins etc.) and genetic medicine (AAV, LNPs, Cell Therapy). AbbVie is seeking a highly motivated candidate for the position of Senior Scientist II, located in North Chicago, IL. We are seeking an accomplished scientist with a proven track record in biologics drug product formulation development, predictive stability, in-use, and quality risk management (QRM) . This position will be an integral part of the product development and CMC teams and will have strong collaborations with several stakeholders, including discovery research, analytical research and development, bioprocess development, combination products development, product development science and technology, pilot plants and third-party manufacturers. Key Responsibilities: Lead matrix drug product teams for one or more internal and external projects and represent Bio --- TITLE: Executive Director, AI/ML Drug Discovery Analytics EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $326K-$383K POSTED: 2026-04-10 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695158003 EXCERPT: Executive Director, AI/ML Drug Discovery Analytics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As Executive Director, AI/ML Drug Discovery Analytics, you will be a senior leader shaping the future of data-driven drug discovery at Revolution Medicines. You will define the Research's AI/ML strategy, oversee implementation of advanced analytics across discovery and build a world-class team to unlock the full potential of our rich internal datasets and make these insights accessible to other scientist. Your leadership will directly influence early discovery innovation, pipeline acceleration, and strategic portfolio decisions. Responsibilities include: Technical Leadership and Innovation: You will have a deep understanding of Machine Learning Operations and AI system design. Design and scale a robust ML infrastructure, integrating MLOps best practices to ensure seamless development, deployment, and monitoring of AI/ML models. Drive innovation in applying deep learning, generative models, and diffusion models to drug discovery, including target prediction, hit identification, and lead optimization. Leverage RevMed's unique datasets --- TITLE: Sr Therapeutic Specialist, HIV Treatment- Washington EMPLOYER: Gilead Sciences LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Sr-Therapeutic-Specialist--HIV-Treatment--Washington_R0051936-2 EXCERPT: Sr Therapeutic Specialist, HIV Treatment- Washington 2 Locations posted: Posted 30+ Days Ago --- TITLE: Director, Regulatory Strategy EMPLOYER: Rapport Therapeutics Inc LOCATION: 99 High Street, Suite 2100 , Boston, MA 02110 (unspecified) SALARY: $220K-$240K POSTED: 2026-01-24 APPLY_URL: https://www.rapportrx.com/careers-board/?gh_jid=5001273007 EXCERPT: Director, Regulatory Strategy 99 High Street, Suite 2100 , Boston, MA 02110 When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we're driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we're doing this with extraordinary science and awesome people (affectionately called Rapptors). Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder. The strength of Rapport comes from our Rapptors - who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you're as excited about this opportunity as we are! Your Impact: The Director of Regulatory Strategy will play a pivotal role in leading strategic regulatory initiatives for assigned drug development programs. Your Day-to-Day: - Create and implement innovative and effective regulatory strategies to support the development of Rapport global drug development programs - Provide regulatory expertise and advise to cross-functional team --- TITLE: Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet) EMPLOYER: AbbVie Inc. LOCATION: Ludwigshafen, RP, Germany (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990012977056-chemielaborant-pharmakant-chemikant-pta-cta-bta-fur-die-herstellung-parenteraler-klinischer-prufpraparate-all-genders-vollzeit-unbefristet- EXCERPT: Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet) Ludwigshafen, RP, Germany Unternehmensbeschreibung: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Stellenbeschreibung: Herzlich willkommen bei Abbvie! Als Teil eines internationalen Unternehmens mit über 48.000 Mitarbeitern weltweit und rund 3.000 Mitarbeitern in Deutschland hast Du die Möglichkeit, eng mit uns zusammenzuarbeiten, um die gesundheitlichen Herausforderungen von morgen zu meistern. Du hast eine Leidenschaft für die Verbesserung der Gesundheitsversorgung auf der ganzen Welt? Du möchtest Dein Fachwissen einsetzen, um die Lebensqualität von Patienten zu verbessern? In einem herausfordernden Arbeitsumfeld, das Dir die Möglichkeit bietet, Deine eigenen Fähigkeiten zu erweitern und zu entwickeln? Dann bist Du bei uns richtig! Gemeinsam großes bewegen - als Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) Für unser motiviertes und engagiertes Team in der Entwicklung und Herstellung von parenteralen Arzneiformen suchen wir tatkräftige Unterstützung. Routine ist uns fremd, da unsere Abteilung an innovativen Prozessen und Produkten für klinische Studien arbeitet und einen reibungslosen Transfer aus der Entwicklung in die Herstellung klinischer Prüfpräparate gewährleistet. Unsere Aufgaben und Chargengrößen passen sich den jeweiligen Forschungs- und Entwicklungsprojekten --- TITLE: (Jr/Sr) Therapeutic Advisor - salesfunctie regio Groningen/Drenthe/Friesland EMPLOYER: Eli Lilly and Company LOCATION: Netherlands, Remote (remote) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://lilly.wd5.myworkdayjobs.com/LLY/job/Netherlands-Remote/XMLNAME--Jr-Sr--Therapeutic-Advisor---salesfunctie-regio-Groningen-Drenthe-Friesland_R-105413 EXCERPT: (Jr/Sr) Therapeutic Advisor - salesfunctie regio Groningen/Drenthe/Friesland Netherlands, Remote posted: Posted 30+ Days Ago --- TITLE: Therapeutic Area Lead Oncology GU-Hem EMPLOYER: AstraZeneca LOCATION: Austria - Vienna (unspecified) SALARY: Not disclosed POSTED: 2026-06-05 K401_MATCH: yes (not source-backed) APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/Austria---Vienna/Therapeutic-Area-Lead-Oncology-GU-Hem_R-228988-1 EXCERPT: Therapeutic Area Lead Oncology GU-Hem Austria - Vienna posted: Posted 7 Days Ago --- TITLE: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy - San Francisco CA EMPLOYER: Bristol Myers Squibb LOCATION: San Francisco - CA - US (unspecified) SALARY: Not disclosed POSTED: 2026-06-03 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/San-Francisco---CA---US/Senior-Therapeutic-Area-Specialist--Neuroscience---Cobenfy---San-Francisco-CA_R1600474-3 EXCERPT: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy - San Francisco CA San Francisco - CA - US posted: Posted 9 Days Ago --- TITLE: Executive Director, Therapeutic Area Strategy, Oncology and Hematology EMPLOYER: Novartis LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/East-Hanover/Executive-Director--Therapeutic-Area-Strategy--Oncology_REQ-10076159 EXCERPT: Executive Director, Therapeutic Area Strategy, Oncology and Hematology 2 Locations posted: Posted 30+ Days Ago --- TITLE: Scientist, Drug Product Analytical EMPLOYER: NewLimit LOCATION: South San Francisco (unspecified) SALARY: $130K-$170K POSTED: 2026-05-01 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/newlimit/jobs/5986881004 EXCERPT: Scientist, Drug Product Analytical South San Francisco About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We're developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale. Position We are seeking a skilled and motivated Scientist to join our Delivery Sciences team. In this role, you will focus on building the analytical methods to characterize Lipid Nanoparticles (LNPs) to enable our nucleic acid delivery technologies and support the drug product development. Expertise in developing and implementing analytical methods to characterize RNA drug substances and LNP drug products, with experience managing method qualification, validation, and tech-transfer processes. What you'll do In your role as a Scientist, you will: - Design and execute analytical methods to assess the identity, integrity and purity of RNA drug substances and LNP drug products and LNP-conjugates - Perform deep-dive analysis into mRNA integrity, identity, lipid content and identity analysis to support drug product stability studies - Work closely with the cross-functional teams to support RNA and LNP analysis for drug development from early discovery to GLP/GMP stages. Act as a technical expert for our CRO/CDMO partners on drug substance and drug product analytical method development, validation phases and PK/PD assay developments - Interpret data from various analytical assays, reports and prepare data packages - --- TITLE: Associate Director, Global Omnichannel Solutions Delivery EMPLOYER: Revolution Medicines LOCATION: Redwood City, California, United States (unspecified) SALARY: $186K-$233K POSTED: 2026-05-22 K401_MATCH: yes (not source-backed) APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7655280003 EXCERPT: Associate Director, Global Omnichannel Solutions Delivery Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: RevMed is seeking a strategic and experienced technology leader to join our Information Sciences (IS) team as Associate Director, Global Omnichannel Solutions Delivery. This role will ensure our omnichannel technology ecosystem is connected, scalable, and globally ready, enabling seamless customer experiences across markets outside of the US. The individual will play a critical role in supporting global expansion by establishing scalable solutions, enabling adoption of global platforms, and ensuring new capabilities, brands, and regions can be added efficiently without rework or fragmentation. The ideal candidate brings strong technical acumen, experience working across multiple marketing technologies, and the ability to translate complex business needs into scalable, globally consistent solutions. Key responsibilities: Global Omnichannel Enablement - Lead deployment of integrated customer journeys across ex-US markets, ensuring alignment with global platform strategy. - Enable launch, medical, and global expansion priorities through scalable solution enablement. --- TITLE: Sr Therapeutic Specialist, HIV Prevention- Minneapolis, MN EMPLOYER: Gilead Sciences LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Sr-Therapeutic-Specialist--HIV-Prevention--Minneapolis--MN_R0052213-2 EXCERPT: Sr Therapeutic Specialist, HIV Prevention- Minneapolis, MN 2 Locations posted: Posted 30+ Days Ago --- TITLE: Senior Therapeutic Specialist - Hepatitis B/D Hartford, CT EMPLOYER: Gilead Sciences LOCATION: 3 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Senior-Therapeutic-Specialist---Hepatitis-B-D-Hartford--CT_R0051454-2 EXCERPT: Senior Therapeutic Specialist - Hepatitis B/D Hartford, CT 3 Locations posted: Posted 30+ Days Ago --- TITLE: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy - Glendale, CA EMPLOYER: Bristol Myers Squibb LOCATION: GLENDALE - CA - US (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/GLENDALE---CA---US/Senior-Therapeutic-Area-Specialist--Neuroscience---Cobenfy---Glendale--CA_R1601209 EXCERPT: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy - Glendale, CA GLENDALE - CA - US posted: Posted 30+ Days Ago --- TITLE: Therapeutic Strategy VP, Infectious Disease/Respiratory (Home - Based) EMPLOYER: IQVIA LOCATION: 4 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-28 K401_MATCH: yes (not source-backed) APPLY_URL: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Durham-North-Carolina-United-States-of-America/Therapeutic-Strategy-VP--Infectious-Disease-Respiratory--Home---Based-_R1531655 EXCERPT: Therapeutic Strategy VP, Infectious Disease/Respiratory (Home - Based) 4 Locations posted: Posted 15 Days Ago --- TITLE: Senior Director, Clinical Development EMPLOYER: Definium Therapeutics LOCATION: Remote (remote) SALARY: $248K-$299K POSTED: 2026-06-04 APPLY_URL: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5808053004 EXCERPT: Senior Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Sr. Director, Clinical Development will play a key role in the design and execution of ongoing and new clinical studies and contribute to the clinical development plan for one or more programs. The position will successfully lead and/or serve as the clinical science representative on one or more clinical studies (US and/or global) to deliver high quality data for registration. The position requires the --- TITLE: Senior Medical Science Liaison - Southeast Region (Baltimore, Virginia, Washington DC) EMPLOYER: Cogent Biosciences Inc LOCATION: Remote, United States (remote) SALARY: $205K-$240K POSTED: 2026-03-23 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4194124009 EXCERPT: Senior Medical Science Liaison - Southeast Region (Baltimore, Virginia, Washington DC) Remote, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Senior Medical Science Liaison (MSL) will serve as a senior field-based scientific expert supporting Cogent Biosciences' lead program, bezuclastinib. This role focuses on scientific engagement across oncology (solid tumors/sarcoma, including Gastrointestinal Stromal Tumor [GIST]), hematology/oncology (Non-Advanced and Advanced Systemic Mastocytosis), and allergy/immunology (Non-Advanced Systemic Mastocytosis) within the assigned territory. The Senior MSL will collaborate with cross-functional partners to develop strategic, scientifically aligned regional business plans that support corporate objectives. The Senior MSL will mentor colleagues, work closely with Field Medical Affairs Area Directors and Medical Strategy, and ensure consistency in scientific communication nationally. This role will also contribute to ongoing education for Medical Affairs, Patient Advocacy, and Commercial --- TITLE: Senior Director, Therapeutic Area (Hepatology) EMPLOYER: Piedmont Healthcare LOCATION: US, Blue Bell (ICON) (unspecified) SALARY: Not disclosed POSTED: 2026-06-03 K401_MATCH: yes (not source-backed) APPLY_URL: https://icon.wd3.myworkdayjobs.com/broadbean_external/job/US-Blue-Bell-ICON/Senior-Director--Therapeutic-Area--Hepatology-_JR148045 EXCERPT: Senior Director, Therapeutic Area (Hepatology) US, Blue Bell (ICON) posted: Posted 9 Days Ago --- TITLE: Senior Scientist, Oligonucleotide Therapeutics EMPLOYER: Insitro LOCATION: South San Francisco, CA (unspecified) SALARY: $156K-$176K POSTED: 2026-05-07 K401_MATCH: yes (not source-backed) MENTAL_HEALTH_SUPPORT: yes (not source-backed) APPLY_URL: https://jobs.ashbyhq.com/insitro/95d5e54f-9dcd-4954-88a4-fd4c8443d45a EXCERPT: Senior Scientist, Oligonucleotide Therapeutics South San Francisco, CA The Opportunity At the heart of insitro's strategy is to generate multi-modal phenotypic cellular data in our automated laboratories for our cell machine learning platform and utilize high content human clinical, imaging and genetic data in our clinical machine learning platform to unlock and de-risk novel therapeutic targets for drug discovery. Our drug discovery efforts span from small molecules to oligonucleotides. We are seeking a highly motivated scientist to support our growing efforts in the oligonucleotide drug discovery space. This role will report to the head of our oligonucleotide drug discovery. In this role the candidate will get an opportunity to work across targets and therapeutic areas and will be supporting oligonucleotide drug discovery and tech dev encompassing several modalities such as siRNAs, ASOs and mRNA. The ideal candidate will be working in a highly collaborative environment with our therapeutic area scientists, AI/ML scientists, and chemists, to bring transformative medicines to patients faster. You will be joining a vibrant biotech startup that has long-term stability, with significant funding, and in a high-growth phase, and you will have many opportunities to make a significant impact. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro's culture, strategic direction, and outcomes. Join us, and help make a difference to patients! This is an onsite role based in insitro's South San Francisco headquarters, coming onsite 3-4 days a week. Responsibilities - Design and optimize siRNA, antisense --- TITLE: Sr Director, Protein Therapeutics EMPLOYER: Gilead Sciences LOCATION: United States - California - Foster City (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---California---Foster-City/Sr-Director--Protein-Therapeutics_R0051094-1 EXCERPT: Sr Director, Protein Therapeutics United States - California - Foster City posted: Posted 30+ Days Ago --- TITLE: Principal Research Scientist I, Biologics Screening - Discovery Biotherapeutics EMPLOYER: AbbVie Inc. LOCATION: San Francisco, CA, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990012912319-principal-research-scientist-i-biologics-screening-discovery-biotherapeutics EXCERPT: Principal Research Scientist I, Biologics Screening - Discovery Biotherapeutics San Francisco, CA, United States Company Description: AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas - immunology, oncology, neuroscience, and eye care - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on X , Facebook , Instagram , YouTube , LinkedIn and Tik Tok . Job Description: Discovery Biotherapeutics and Genetic Medicine (BGM) at AbbVie is seeking a highly motivated Principal Scientist to join the Biotherapeutics group at the AbbVie Bay Area (ABA) site based in South San Francisco, CA. This role seeks a skilled and experienced individual to contribute to and lead therapeutic programs, focusing on biophysical screening to advance biotherapeutics from early exploration through lead identification and optimization. Close partnerships with Oncology will be required to drive transformative ideas to the clinic. The ideal candidate must possess expertise in high-throughput biologics screening and characterization methods (e.g. ELISA, FACS, BLI, SPR, etc.) and have a solid foundation in protein sciences and antibody discovery with a proven ability to work effectively on cross-functional teams. Responsibilities Lead from the lab to advance large molecule biologics projects from exploratory to optimization stages and drive Go / No Go decisions. Effectively partner with functional and therapeutic areas to achieve --- TITLE: Senior Therapeutic Area Specialist, Hematology- Charleston, SC EMPLOYER: Bristol Myers Squibb LOCATION: 3 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-15 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Charleston---SC---US/Senior-Therapeutic-Area-Specialist--Hematology--Charleston--SC_R1602421 EXCERPT: Senior Therapeutic Area Specialist, Hematology- Charleston, SC 3 Locations posted: Posted 28 Days Ago --- TITLE: Senior Principal Research Scientist, Computational Drug Discovery Optimization Team Lead EMPLOYER: AbbVie Inc. LOCATION: North Chicago, IL, United States (unspecified) SALARY: Not disclosed POSTED: 2026-06-10 PARENTAL_LEAVE_WEEKS: 12 (not source-backed) NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed) K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990012924307-senior-principal-research-scientist-computational-drug-discovery-optimization-team-lead EXCERPT: Senior Principal Research Scientist, Computational Drug Discovery Optimization Team Lead North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: Purpose: This position brings an opportunity to make innovative contributions that will define how AbbVie leverages AI-enabled drug discovery across our small molecule portfolio. Reports to Head of Computational Drug Discovery (CDD) and will lead the computational Lead Optimization team. Will implement and enable collaborative design between members of the Optimization team and Global Medicinal Chemistry (GMEC) teams. Must possess strong expertise in modern medicinal chemistry, including a deep understanding of modern computational and experimental strategies, property-based drug design, and pharmacology needed to develop low-dose small molecule drug candidates. The ideal candidate will have a strong and established background in drug discovery from exploratory through candidate nomination including an established external footprint, and network as well as a proven track record of successfully leading diverse project teams to identify novel drug candidates. Past experience will have included mentorship of early/mid-career scientists in matrixed and/or direct reporting relationships. Responsibilities: Consult with project team and --- TITLE: Therapeutic Specialist Oncology - Veneto / Friuli Venezia Giulia EMPLOYER: Gilead Sciences LOCATION: Italy - Padova (unspecified) SALARY: Not disclosed POSTED: 2026-05-26 K401_MATCH: yes (not source-backed) APPLY_URL: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Italy---Padova/Therapeutic-Specialist-Oncology---Veneto---Friuli-Venezia-Giulia_R0050697-2 EXCERPT: Therapeutic Specialist Oncology - Veneto / Friuli Venezia Giulia Italy - Padova posted: Posted 17 Days Ago --- TITLE: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy; Birmingham, AL EMPLOYER: Bristol Myers Squibb LOCATION: Birmingham - AL - US (unspecified) SALARY: Not disclosed POSTED: 2026-06-04 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Birmingham---AL---US/Senior-Therapeutic-Area-Specialist--Neuroscience---Cobenfy--Birmingham--AL_R1599301 EXCERPT: Senior Therapeutic Area Specialist, Neuroscience - Cobenfy; Birmingham, AL Birmingham - AL - US posted: Posted 8 Days Ago --- TITLE: Senior Manager Data Products – Therapeutic Area (TA) EMPLOYER: Johnson & Johnson LOCATION: 5 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-03 K401_MATCH: yes (not source-backed) APPLY_URL: https://jj.wd5.myworkdayjobs.com/JJ/job/Titusville-New-Jersey-United-States-of-America/Senior-Manager-Data-Products---Therapeutic-Area--TA-_R-079433-1 EXCERPT: Senior Manager Data Products – Therapeutic Area (TA) 5 Locations posted: Posted 9 Days Ago --- TITLE: Senior Therapeutic Area Specialist, Hematology- Frederick/Fairfax, VA EMPLOYER: Bristol Myers Squibb LOCATION: 4 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-06-08 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Fairfax---VA---US/Senior-Therapeutic-Area-Specialist--Hematology--Frederick-Fairfax--VA_R1602343 EXCERPT: Senior Therapeutic Area Specialist, Hematology- Frederick/Fairfax, VA 4 Locations posted: Posted 4 Days Ago --- TITLE: Research Associate, In Vivo Pharmacology EMPLOYER: Korro Bio Inc LOCATION: 60 First St, Cambridge, MA 02141 (unspecified) SALARY: Not disclosed POSTED: 2026-05-19 K401_MATCH: yes (not source-backed) APPLY_URL: https://jobs.lever.co/korrobio/9e82dc48-5fe9-43ba-b333-c93f8d656132 EXCERPT: Research Associate, In Vivo Pharmacology 60 First St, Cambridge, MA 02141 Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health. Korro Bio is seeking a highly motivated Research Associate to join --- TITLE: Therapeutic Area Specialist, Aichi Sangi, HEMA EMPLOYER: Bristol Myers Squibb LOCATION: Field - Japan - JP (unspecified) SALARY: Not disclosed POSTED: 2026-05-27 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Field---Japan---JP/Therapeutic-Area-Specialist--Aichi-Sangi--HEMA_R1602828 EXCERPT: Therapeutic Area Specialist, Aichi Sangi, HEMA Field - Japan - JP posted: Posted 16 Days Ago --- TITLE: Associate Scientist I, Immunology EMPLOYER: Tonix Pharmaceuticals Holding Corp LOCATION: Frederick, MD 21701 (unspecified) SALARY: $50K-$70K POSTED: 2026-05-18 K401_MATCH: yes (not source-backed) APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009 EXCERPT: Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate --- TITLE: Senior Therapeutic Area Specialist, Hematology- Sacramento, CA EMPLOYER: Bristol Myers Squibb LOCATION: Sacramento - CA - US (unspecified) SALARY: Not disclosed POSTED: 2026-06-11 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Sacramento---CA---US/Senior-Therapeutic-Area-Specialist--Hematology--Sacramento--CA_R1598982-3 EXCERPT: Senior Therapeutic Area Specialist, Hematology- Sacramento, CA Sacramento - CA - US posted: Posted Yesterday --- TITLE: Senior Therapeutic Area Specialist, Hematology- Manhattan, NY EMPLOYER: Bristol Myers Squibb LOCATION: 2 Locations (unspecified) SALARY: Not disclosed POSTED: 2026-05-12 K401_MATCH: yes (not source-backed) APPLY_URL: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Field---United-States---US/Senior-Therapeutic-Area-Specialist--Hematology--Manhattan--NY_R1602140 EXCERPT: Senior Therapeutic Area Specialist, Hematology- Manhattan, NY 2 Locations posted: Posted 30+ Days Ago --- [PASTE YOUR RESUME OR SKILLS HERE]